Forest Laboratories Inc. and a subsidiary will pay $38 million to resolve allegations they tried to increase drug sales by providing cash and gifts while encouraging marketing the drugs’ use for nonapproved purposes United States v. Forest Pharmaceuticals, Inc., E.D. Wis., 12-cv-00366, settlement 12/15/16.
The Justice Department Dec. 15 announced the settlement, which didn’t have a determination of liability, based on an April 18, 2012 complaint developed with the assistance of Kurt Kroening, a whistle-blower who was a Forest Laboratories sales representative. He will receive about $7.8 million. The ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.